Evidence map›Paper›PMID 27887617›Full record

ArticleRespiratory research2016

Increased expression of TROP2 in airway basal cells potentially contributes to airway remodeling in chronic obstructive pulmonary disease.

Qixiao Liu, Haijun Li, Qin Wang, Yuke Zhang, Wei Wang, Shuang Dou, Wei Xiao

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. High BMP7 Expression May Worsen Airway Disease in COPD by Altering Epithelial Cell Behavior.International journal of chronic obstructive pulmonary disease · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Basic Science Perspective on Engineering and Modeling the Large Airways.Advances in experimental medicine and biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Qixiao LiuDepartment of Respiratory Medicine, Qilu Hospital, Shandong University, 107 Wenhua West Road, Jinan, China.
Haijun LiDepartment of Cadre Health Care, Qilu Hospital, Shandong University, 107 Wenhua West Road, Jinan, China.
Qin WangDepartment of Anesthesiology, Qilu Hospital, Shandong University, 107 Wenhua West Road, Jinan, China.
Yuke ZhangDepartment of Cadre Health Care, Qianfoshan Hospital, 16766 Jingshi Road, Jinan, China.
Wei WangDepartment of Respiratory Medicine, Qilu Hospital, Shandong University, 107 Wenhua West Road, Jinan, China.
Shuang DouDepartment of Respiratory Medicine, Qilu Hospital, Shandong University, 107 Wenhua West Road, Jinan, China.
Wei XiaoDepartment of Respiratory Medicine, Qilu Hospital, Shandong University, 107 Wenhua West Road, Jinan, China. xiaowei4226@163.com.
Qilu Hospital of Shandong University · CNShandong Provincial QianFoShan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe airway epithelium of chronic obstructive pulmonary disease (COPD) patients undergoes aberrant repair and remodeling after repetitive injury following exposure to environmental factors. Abnormal airway regeneration observed in COPD is thought to originate in the stem/progenitor cells of the airway epithelium, the basal cells (BCs). However, the molecular mechanisms underlying these changes remain unknown. Here, trophoblast cell surface antigen 2 (TROP2), a protein implicated in the regulation of stem cell activity, was examined in lung tissue samples from COPD patients.

methodsThe expression of TROP2 and hyperplasia index Ki67 was assessed in lung epithelium specimens from non-smokers (n = 24), smokers (n = 24) and smokers with COPD (n = 24). Primary airway BCs were isolated by bronchoscopy from healthy individuals and COPD patients and subsequently transfected with pcDNA3.1-TROP2 or siRNA sequence in vitro. The functional consequences of TROP2 overexpression in BCs were explored.

resultsImmunohistochemistry and immunofluorescence revealed increased TROP2 expression in airway BCs in smokers with COPD compared to nonsmokers and smokers without COPD, and staining was highly localized to hyperplastic regions containing Ki67 positive cells. TROP2 expression was also inversely correlated with airflow limitation in patients with COPD (r = -0.53, P < 0.01). pcDNA3.1-TROP2-BCs in vitro exhibited improved proliferation with activation of ERK1/2 phosphorylation signaling pathway. In parallel, changes in vimentin and E-cadherin in pcDNA3.1-TROP2-BCs were consistent with an epithelial-mesenchymal transition (EMT)-like change, and secretion of inflammatory factors IL-1β, IL-8 and IL-6 was increased. Moreover, down-regulation of TROP2 by siRNA significantly attenuated the proliferation of BCs derived from COPD patients. EMT-like features and cytokine levels of COPD basal cells were also weakened following the down-regulation of TROP2.

conclusionThe results indicate that TROP2 may play a crucial role in COPD by affecting BC function and thus airway remodeling through increased BC hyperplasia, EMT-like change, and introduction of inflammatory molecules into the microenvironment.

Indexed as

Airway RemodelingAgedAntigens, NeoplasmCell Adhesion MoleculesCell ProliferationCytokinesEpithelial CellsEpitheliumFemaleHumansImmunohistochemistryInflammationKi-67 AntigenMaleMAP Kinase Signaling SystemMiddle AgedAntigens, NeoplasmCell Adhesion MoleculesCytokinesKi-67 AntigenRNA, Small InterferingTACSTD2 protein, humanAirway remodelingBasal cellsChronic obstructive pulmonary disease (COPD)Cigarette smokeTrophoblast cell surface antigen 2 (TROP2)

Identifiers

PMID27887617
PMCPMC5124273
OpenAlexW2556067056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.